Study finds children with residual amblyopia did not find an advantage with levodopa

Article

A recent study of children ages 7 to 12 with residual amblyopia did not find an advantage with the use of levodopa compared with a placebo group, according to Michael X. Repka, MD, MBA.

Baltimore-A recent study of children ages 7 to 12 with residual amblyopia did not find an advantage with the use of levodopa compared with a placebo group, according to Michael X. Repka, MD, MBA. 

 

Read the results of the study here.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD; detailed what optometrists can expect to change when HB 1353's regulations are enacted later this year.
Arkansas Optometric Association legislative cochairs Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD, discuss their involvement in their bill and provide context for its relevance.
Elise Kramer, OD, FAAO, FSLS, describes her take on a multidisciplinary approach to dry eye
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Paul Karpecki, OD, FAAO
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Related Content
Red light grid Image credit: AdobeStock/VictorMoussa

Changes in cone density after low-level red light treatment in children with myopia

Lynda Charters
April 25th 2025
Article
New Opportunities in Topical Glaucoma Management

New Opportunities in Topical Glaucoma Management

Mitch Ibach, OD, FAAO;Jessica Steen, OD, FAAO
January 31st 2025
Podcast
IOL being placed in container. Image credit: AdobeStock/Oktay

Bausch + Lomb identifies issue causing recall in enVista platform, returns product to market

Martin David Harp, Editor, Ophthalmology Times
April 24th 2025
Article
You and Eye: Vision training research in eSports - with Tiffany Tsoi, OD, FAAO

You and Eye: Vision training research in eSports - with Tiffany Tsoi, OD, FAAO

Miriam Korik, OD;Tiffany Tsoi, OD;Emily Kaiser Maharjan, Assistant Managing Editor
December 4th 2024
Podcast
Atropine 0.05% receives CDSCO approval in India for myopia management. - Image credit:©vitalis83 – stock.adobe.com

ENTOD Pharmaceuticals announces CDSCO approval of 0.05% atropine drops in India

Hattie Hayes;Emily Kaiser Maharjan, Assistant Managing Editor;Jordana Joy, Associate Editor
April 23rd 2025
Article
An image of the laboratory with students working at stations Image credit: Seneca Polytechnic

New HOYA Vision Care Eyeglass Dispensing Lab available for Seneca Polytechnic opticianry students

Jordana Joy, Associate Editor
April 23rd 2025
Article
© 2025 MJH Life Sciences

All rights reserved.